Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's EBIT?
- West Pharmaceutical Services (WST) reported EBIT of $179.1M in Q2 2026.
- How has West Pharmaceutical Services's EBIT changed year-over-year?
- West Pharmaceutical Services's EBIT increased by 16.5% year-over-year, from $153.7M to $179.1M.
- What is the long-term trend for West Pharmaceutical Services's EBIT?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's EBIT has grown at a -6.1% compound annual growth rate (CAGR), from $752.3M to $584.9M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about West Pharmaceutical Services's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude